Natrix Separations Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Natrix Separations Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7534
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies, a subsidiary of Merck KGaA, is a supplier of single use and multi-cycle disposable chromatography products. The company offers NatriFlo HD-Q membrane adsorbers, an advanced material with a three-dimensional macroporous hydrogel structure that provides high density of binding sites and rapid mass transfer. Its HD-Q membrane adsorbers find application in single-use flow-through polish applications. Natrix supplies multi-cycle disposable chromatography products for life science, food, beverage and water markets. The company’s HD membrane technology offers breakthrough in membrane architecture that changes downstream purification. It markets its products through a network of distributors in Europe, North America and Asia. Natrix Separation is headquartered in Burlington, Ontario, Canada.

Natrix Separations Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natrix Separations Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Natrix Separations Enters into Co-Development Agreement with Merck and Sanofi 9
Natrix Separations Enters into Co-Development Agreement with Scil Proteins 10
Acquisition 11
Merck to Acquire Natrix Separations 11
JSR Acquires Minority Stake In Natrix Separations, Biotech Company 12
Natrix Separations Inc – Key Competitors 13
Natrix Separations Inc – Key Employees 14
Natrix Separations Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Natrix Separations Inc, Pharmaceuticals & Healthcare, Key Facts 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natrix Separations Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Natrix Separations Enters into Co-Development Agreement with Merck and Sanofi 9
Natrix Separations Enters into Co-Development Agreement with Scil Proteins 10
Merck to Acquire Natrix Separations 11
JSR Acquires Minority Stake In Natrix Separations, Biotech Company 12
Natrix Separations Inc, Key Competitors 13
Natrix Separations Inc, Key Employees 14

List of Figures
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Natrix Separations Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Breeze-Eastern Corporation:企業の戦略・SWOT・財務情報
    Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report Summary Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • New World Development Co Ltd (17):企業の財務・戦略的SWOT分析
    New World Development Co Ltd (17) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Gilbane Inc:企業の戦略・SWOT・財務情報
    Gilbane Inc - Strategy, SWOT and Corporate Finance Report Summary Gilbane Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kinross Gold Corp:企業の戦略・SWOT・財務情報
    Kinross Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Kinross Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PeptiDream Inc (4587)-製薬・医療分野:企業M&A・提携分析
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform. Its technologies i …
  • Acerinox Group:企業の戦略・SWOT・財務情報
    Acerinox Group - Strategy, SWOT and Corporate Finance Report Summary Acerinox Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • VINCI Energies:企業のM&A・事業提携・投資動向
    VINCI Energies - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VINCI Energies Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • KBC Group NV:企業の戦略・SWOT・財務情報
    KBC Group NV - Strategy, SWOT and Corporate Finance Report Summary KBC Group NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • aap Implantate AG (AAQ):企業の財務・戦略的SWOT分析
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …
  • Graham Holdings Company (GHC):企業の財務・戦略的SWOT分析
    Graham Holdings Company (GHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Valeant Canada LP-製薬・医療分野:企業M&A・提携分析
    Summary Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical company that manufactures, markets and distributes pharmaceutical products. The company offers its products in various therapeutic areas, including pain management, neurology, c …
  • CS Energy Ltd:企業の戦略的SWOT分析
    CS Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • United States Postal Service:企業の戦略的SWOT分析
    United States Postal Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • CHDI Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CHDI Foundation Inc (CHDI) is a non-profit biomedical research organization that discovers and develops drugs for Huntington’s disease. The organization’s activities include identification and validation of therapeutic targets, drug discovery and development, and clinical studies and trials. …
  • Equipos Nucleares SA:企業の戦略的SWOT分析
    Equipos Nucleares SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Neiman Marcus Group Ltd. LLC:企業の戦略的SWOT分析
    Neiman Marcus Group Ltd. LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Sinochem Group:企業の戦略・SWOT・財務分析
    Sinochem Group - Strategy, SWOT and Corporate Finance Report Summary Sinochem Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Arix Bioscience Plc (ARIX):企業の財務・戦略的SWOT分析
    Arix Bioscience Plc (ARIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Summit Exploration and Production Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Summit Exploration and Production Ltd (Summit), a subsidiary of Sumitomo Corp, is an independent upstream oil and gas company that explores, develops and produces oil and gas assets. The company holds operator interests for exploration in the UK North Sea. It has two production assets such a …
  • American Woodmark Corp (AMWD):企業の財務・戦略的SWOT分析
    American Woodmark Corp (AMWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆